Press Releases from IonGate Biosciences GmbH (6 total)
IonGate honored for its SURFE2R Technology as “Landmark in the Land of Ideas 2 …
Frankfurt/Main (Germany), November 18, 2008. IonGate Biosciences GmbH celebrated its election as “Landmark in the Land of Ideas“ by the initiative “Germany – Land of Ideas”. IonGate’s patented SURFE2R Technology (SURFace Electrogenic Event Reader) won the jury’s acclaim in the nationwide contest “365 Landmarks in the Land of Ideas”. SURFE2R Technology enables scientists to detect extremely small electric currents in cell membranes. Thus, it becomes possible to analyze the otherwise…
IonGate boosts marketing and sales efforts in the US with new funding
Frankfurt/Main (Germany), 17th September 2008. IonGate Biosciences GmbH announces the closing of a new round of funding amounting to EUR 1 million. The capital contribution comes in as the new investor Hessen Kapital I GmbH joins in a silent partnership with IonGate and it will be used for further expansion of the US business as well as for the increase of the global commercialization of SURFE2R Technology (SURFace Electrogenic Event…
IonGate increases throughput for transporter-based drug discovery with new SURFE …
Frankfurt/Main (Germany), 28th July 2008. IonGate Biosciences GmbH is pleased to announce the market launch of the innovative SURFE2R Workstation 5000. This fully integrated screening center is the new flagship model of IonGate’s SURFE2R product family, paving new ways in industrial automation of transporter screening for the pharmaceutical industry.
With SURFE2R Workstation 5000, IonGate presents the latest automated system for direct functional measurement of the important new target class of transport…
ARTEL and IonGate Join Forces to Advance Drug Discovery Research in North Americ …
Westbrook, ME (USA), Frankfurt / Main (Germany), 24th June, 2008. ARTEL and IonGate Biosciences announced their strategic partnership to support the growing application of IonGate’s drug discovery technology. The German biotechnology company will leverage ARTEL’s local infrastructure, customer relationships and market knowledge to increase the exposure and use of its discovery systems and assay development services in North America. The partnership will focus on IonGate’s SURFE2R Technology, which enables more…
IonGate at the SBS Symposium Europe in Dresden
Frankfurt/Main (Germany), 6th June 2008. IonGate Biosciences GmbH will present relevant application fields for the proprietary SURFE2R Technology (SURFace Electrogenic Event Reader) at the SBS Symposium “Label Free Technologies in Drug Discovery” in Dresden, Germany. The meeting is being held at the international congress center on June 10 – 11.
Dr. Henning Vollert will explain the advantages of the cell- and label-free technology in comparison to the more conventional patch clamp…
IonGate hosts workshop and presents new SURFE2R prototype at SBS 2008
Frankfurt/Main (Germany), March 31, 2008. IonGate Biosciences GmbH will present its SURFE2R Technology for label-free and automatic measurement of transport proteins in a workshop at the SBS 2008, 14th Annual Conference & Exhibition of the Society of Biomolecular Sciences. The meeting takes place in St. Louis, Missouri, USA, on April 6 – 10, 2008. Additionally IonGate will give an exclusive preview of the prototype for the new SURFE2R Workstation 5000.
Immediately…
